Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Finding
By Jenifer Goodwin, Freelance Writer  |  Thursday, February 6, 2014

Investigators have found a possible molecular explanation for why obese people with kidney cancer tend to fare better despite having a higher rate of diagnosis.

Pictured: Stephen Solomon
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, January 27, 2014

Irreversible electroporation – a new, minimally invasive treatment that uses electric current to poke tiny holes in cell membranes – is showing promise against hard-to-treat tumors.

In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, January 22, 2014

Obesity in patients with early-stage tongue cancer has been linked to a five-fold increase in the risk of death.

Pictured: Alice Ho
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, January 20, 2014

A new approach for treating breast cancer spreads radiation doses over a larger number of beams, providing more thorough coverage.

Pictured: Nai-Kong Cheung & Jeremy D
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, January 9, 2014

Common genetic alterations in neuroblastoma tumors may help doctors predict the likelihood the cancer will spread to the brain.

Pictured: Stem cell-derived nerve cells exposed to progerin
In the Lab
By Jennifer Bell, PhD  |  Monday, December 30, 2013

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.

Pictured: Low-dose CT scans
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 12, 2013

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Casper zebrafish
Snapshot
By Jennifer Bell, PhD  |  Tuesday, December 3, 2013

Physician and cell biologist Richard White has generated a transparent and stripeless strain of zebrafish to study how tumors develop the capacity to metastasize to new organs.

Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 13, 2013

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Pictured: Sarat Chandarlapaty
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 24, 2013

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

Center News

Stay Informed

Get the latest information about cancer care and research every month.